Skip to main content

Institutional intelligence for Ajanta Pharmaceuticals Limited

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters63.48%
  • FII7.68%
  • Mutual Funds18.10%
  • DII (ex-MF)3.70%
  • Retail & others7.04%
  • 1% Club 11.31%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Promoters

Promoter & promoter group

63.48%6 named
HolderStakeSharesValue (₹ Cr)
14.47%1,80,78,148₹6.05k Cr
14.47%1,80,78,147₹6.05k Cr
11.30%1,41,12,924₹4.72k Cr
10.24%1,27,92,904₹4.28k Cr
10.08%1,25,88,393₹4.21k Cr
2.68%33,48,261₹1.12k Cr

Mutual Funds

Domestic mutual funds & UTI

18.10%2 named
HolderStakeSharesValue (₹ Cr)
3.11%38,85,153₹1.30k Cr
1.46%18,22,776₹610.2 Cr

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

11.31%5 named

FII / FPI

Foreign portfolio investors

7.68%No names

No named holders ≥1% in this bucket.

Retail & others

Holders below 1% disclosure threshold and public non-institutions

7.04%

SEBI requires naming only shareholders with ≥1% stake. The remaining 7.04% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

DII (other)

Insurance, banks, AIF, other domestic institutions

3.70%No names

No named holders ≥1% in this bucket.

Super Investors

Curated tracked investor profiles

No names

No curated super investor holds ≥1% in the latest filing. See FII, DII, and mutual fund holders in the sections above.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.